Literature DB >> 8630840

Initiating thrombolytic therapy for acute myocardial infarction: whose job is it anyway?

E Letovsky, T Allen.   

Abstract

Although thrombolytic therapy has clearly become the standard of care for acute myocardial infarction (AMI), its delivery in Canada continues to be extremely variable. Significant unnecessary delays in the initiation of this treatment still occur in many hospitals and constitute the most common avoidable cause of death in patients with AMI. The authors agree with the statement by representatives of the member organizations of the Emergency Cardiac Care Coalition (see pages 483 to 487 of this issue) that emergency service providers must get patients to hospital sooner and that all eligible patients should receive thrombolytic therapy within 30 minutes of their arrival at hospital. This objective requires that thrombolytic therapy be initiated by emergency physicians and be supported by well-established guidelines for its use.

Entities:  

Mesh:

Year:  1996        PMID: 8630840      PMCID: PMC1487621     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Antibiotic guide-lines--do we know where we are going?

Authors:  P J McDonald
Journal:  Med J Aust       Date:  1989-06-05       Impact factor: 7.738

2.  Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project.

Authors:  D J Kereiakes; W D Weaver; J L Anderson; T Feldman; B Gibler; T Aufderheide; D O Williams; L H Martin; L C Anderson; J S Martin
Journal:  Am Heart J       Date:  1990-10       Impact factor: 4.749

3.  An analysis of time delays preceding thrombolysis for acute myocardial infarction.

Authors:  S W Sharkey; D D Bruneete; E Ruiz; W T Hession; D G Wysham; I F Goldenberg; M Hodges
Journal:  JAMA       Date:  1989-12-08       Impact factor: 56.272

4.  Reasons for patients' delay in response to symptoms of acute myocardial infarction.

Authors:  A T Wielgosz; R P Nolan; J A Earp; E Biro; M B Wielgosz
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

5.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

6.  Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London.

Authors:  J S Birkhead
Journal:  BMJ       Date:  1992-08-22

Review 7.  Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction.

Authors:  K Dracup; D K Moser
Journal:  Heart Lung       Date:  1991-09       Impact factor: 2.210

8.  Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group.

Authors:  E R Gonzalez; L A Jones; J P Ornato; G C Bleecker; M J Strauss
Journal:  Ann Emerg Med       Date:  1992-10       Impact factor: 5.721

  8 in total
  1 in total

1.  The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group.

Authors:  J M Brophy; J G Diodati; P Bogaty; P Théroux
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.